Sector in which the organization works:
Short description of the organization and its work to control and eliminate NTDs
About the NTD Program at PATH:
At PATH, we are committed to advancing the tools needed by the NTD community to support global control and elimination of NTDs. As global disease burdens decrease and efforts shift from purely control tactics to elimination strategies, one emerging need is for more sensitive and specific diagnostic tools to monitor progress and continue surveillance in order to prevent disease reintroduction.
To support these control and elimination initiatives, PATH is working with the NTD community to advance appropriate diagnostic tools for Chagas disease, lymphatic filariasis, onchocerciasis, schistosomiasis, and soil-transmitted helminthiases. We are advancing tools that are essential for mapping, monitoring progress for disease control and elimination, and documenting the successes of NTD programs in the post-elimination era.
In addition to our diagnostics work on NTDs, PATH successfully collaborated with a range of partners to develop a drug that offers safe, effective, and affordable treatment for visceral leishmaniasis (VL). We are now exploring new approaches for treating VL to eventually eliminate the disease in the most endemic regions of South Asia, where it poses an especially virulent threat.
PATH is an international organization that drives transformative innovation to save lives and improve health, especially among women and children. We accelerate innovation across five platforms—vaccines, drugs, diagnostics, devices, and system and service innovations—that harness our entrepreneurial insight, scientific and public health expertise, and passion for health equity. By mobilizing partners around the world, we take innovation to scale, working alongside countries primarily in Africa and Asia to tackle their greatest health needs. Together, we deliver measurable results that disrupt the cycle of poor health. Learn more at www.path.org.